A study from Stanford researchers documents "aggressive and deceptive" ways that companies have used COVID-19 to market vaping products.
The pandemic has been what one Stanford psychiatrist called “a mixed bag” for people with addiction issues; some find fewer triggers, others face more.
Stanford-led research examines state rules allowing dispensaries to make erroneous claims about the effectiveness of cannabis in treating opioid addiction.
Alcoholics Anonymous, the fellowship of sobriety seekers, is the most effective path to abstinence, according to a Stanford researcher and collaborators.
Stanford researchers have teased apart the addictive and pro-social effects of MDMA -- suggesting the possibliity of a non-addictive therapy.
Pediatrics professor Bonnie Halpern-Felsher shares her research on teens' perceptions of e-cigarettes and their health risks.
Patients who receive prescriptions for both opioids and benzodiazepines are more likely to use opioids long term, Stanford researchers have found.
Researcher joins Stanford Medicine as a postdoctoral scholar in the Systems Neuroscience and Pain Lab to help others overcome addiction and incarceration.
New Stanford research suggests that young people begin using nicotine products like e-cigarettes by trying fruit, mint or candy flavors.
In an editorial, a Stanford resident argues for the need to enhance physician education about marijuana to help guide clinical decisions.
Teenagers who owned promotional items for nicotine-containing products were twice as likely as other teens to start using the products.
Stanford pain researchers say we can curb the prescription opioid crisis, while treating pain, by using a variety of tactics.
Using human embryonic stem cells to study nicotine's effect in development shows defects in cellular communication and longevity, say Stanford scientists.
Alvin Roth, a Nobel laureate and Stanford faculty member, explains how the economic concept of repugnant markets applies to heroin in the United States.
Small trial conducted by Stanford researchers links activity in the brain's reward processing system with drug relapse in patient cohort.
In this commentary, Stanford tobacco expert Robert Jackler adds context to the recent decision by JUUL to stop direct social media in the U.S.
